Back to search

Combination Immunotherapy with Clinical-Scale Enriched Human γδ T cells, hu14.18 Antibody, and the Immunocytokine Fc-IL7 in Disseminated Neuroblastoma

Data up to Jan 2025

Published2005
Citations43
References42

Total Citations Per Year

Abstract

References (42)

A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

1995 • 5,208 citations

Neuroblastoma: biological insights into a clinical enigma

2003 • 2,087 citations

Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.

1995 • 1,223 citations

γδ Cells: A Right Time and a Right Place for a Conserved Third Way of Protection

2000 • 1,107 citations

Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer: The Childhood Cancer Survivor Study

2001 • 776 citations

γδ T cells for immune therapy of patients with lymphoid malignancies

2003 • 525 citations

Interleukin-7: from bench to clinic

2002 • 496 citations

Metastatic Sites in Stage IV and IVS Neuroblastoma Correlate With Age, Tumor Biology, and Survival

1999 • 405 citations

Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

1984 • 364 citations

Retinoid therapy of high-risk neuroblastoma

2003 • 318 citations

Advances in the Diagnosis and Treatment of Neuroblastoma

2003 • 242 citations

Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo

2003 • 239 citations

IL-7: maintaining T-cell memory and achieving homeostasis

2005 • 232 citations

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma

1995 • 211 citations

Phase II Trial of the Anti-GD2Monoclonal Antibody 3F8 and Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma

2001 • 202 citations

Phase I Study of Chimeric Human/Murine Anti–Ganglioside GD2Monoclonal Antibody (ch14.18) With Granulocyte-Macrophage Colony-Stimulating Factor in Children With Neuroblastoma Immediately After Hematopoietic Stem-Cell Transplantation: A Children’s Cancer Group Study

2000 • 179 citations

Lymphocide: cytokines and the control of lymphoid homeostasis

2002 • 161 citations

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

2004 • 145 citations

Human γδ T cells: a nonredundant system in the immune-surveillance against cancer

2002 • 144 citations

Time-resolved fluorometric assay for natural killer activity using target cells labelled with a fluorescence enhancing ligand

1996 • 115 citations

Immune restoration following hematopoietic stem cell transplantation: an evolving target

2005 • 112 citations

Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study

1998 • 103 citations

Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response

2001 • 94 citations

Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy

2004 • 94 citations

Cytokine functions in the formative stages of a lymphocyte’s life

2004 • 83 citations

High level expression and secretion of Fc-X fusion proteins in mammalian cells

1998 • 80 citations

The role of IL-7 in thymic and extrathymic development of TCR gamma delta cells.

1998 • 71 citations

Biological and clinical implications of interleukin-7 and lymphopoiesis.

1999 • 66 citations

The Role of IL-7 in Thymic and Extrathymic Development of TCRγδ Cells

1998 • 63 citations

Non‐MHC‐restricted cytotoxic cells: their roles in the control and treatment of leukaemias

2001 • 57 citations

Immunogenicity of Human Neuroblastoma

2004 • 53 citations

Human γδ T Lymphocytes Exert Natural and IL–2–Induced Cytotoxicity to Neuroblastoma Cells

2000 • 50 citations

Detection and treatment of minimal residual disease in high‐risk neuroblastoma

2004 • 48 citations

Combination therapy with interleukin-2 and antitumor monoclonal antibodies.

1997 • 44 citations

Human ???? T Cells From G-CSF-Mobilized Donors Retain Strong Tumoricidal Activity and Produce Immunomodulatory Cytokines After Clinical-Scale Isolation

2004 • 35 citations

Differential Roles of Cytokine Receptors in the Development of Epidermal γδ T Cells

2001 • 34 citations

Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: A report from the European Neuroblastoma Study Group ?Survey?

2001 • 33 citations

Development, characterization and therapy of a disseminated model of childhood neuroblastoma in SCID mice

2001 • 31 citations

Handbook of cancer vaccines

2004 • 26 citations

Epidemiology and etiology of neuroblastoma: an overview.

2003 • 20 citations

Immunocytokines for Cancer Immunotherapy

2004 • 11 citations

Efficient killing of neuroblastoma cells by human monocytes activated with recombinant human macrophage colony-stimulating factor and anti-tumor antibody.

1991 • 2 citations

Cited By (0)

No citing papers found in database

Combination Immunotherapy with Clinical-Scale Enriched Human γδ T cells, hu14.18… (2005) – Clinical Cancer Research | Metascience Observatory Explorer